| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |